SCHEMBL6710124

SCHEMBL6710124

Cn1c(C(=O)Nc2ccc(Br)cc2-c2noc(=O)[nH]2)cc2ccc(NC(=O)c3ccco3)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.43
RAB9A P51151 8/20 0.43
SMN1; SMN2 Q16637 6/20 0.42
PKM P14618 2/20 0.41
GPR35 Q9HC97 1/20 0.41
KMT2A Q03164 6/20 0.41
KDM4E B2RXH2 3/20 0.41
HPGD P15428 3/20 0.41
HTT P42858 2/20 0.41
MAPT P10636 8/20 0.41
USP2 O75604 2/20 0.41
PYGM P11217 1/20 0.40
TSHR P16473 3/20 0.40
TP53 P04637 4/20 0.40
MEN1 O00255 4/20 0.39
POLB P06746 4/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 5/20 0.39
GRIK1 P39086 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708544 0.92 ALDH1A1 (0.47) NPC1RAB9ASMN1; SMN2PKMKMT2A
SCHEMBL6709892 0.89 RAB9A (0.41) NPC1RAB9ASMN1; SMN2PKMKMT2A
SCHEMBL6713296 0.88 PYGM (0.40) KMT2AHTTPYGMMEN1GRIK1
SCHEMBL6714295 0.88 GRIK1 (0.41) NPC1RAB9ASMN1; SMN2KMT2AKDM4E
SCHEMBL6713387 0.85 GPR35 (0.45) NPC1RAB9ASMN1; SMN2PKMGPR35
SCHEMBL6707880 0.85 GAA (0.42) NPC1RAB9ASMN1; SMN2KMT2AKDM4E
SCHEMBL6709869 0.84 GRIK1 (0.38) SMN1; SMN2KMT2AKDM4EHPGDHTT
SCHEMBL6710171 0.84 GRIK1 (0.38) KMT2AMAPTMEN1ALDH1A1GRIK1
SCHEMBL6713718 0.84 HPGD (0.40) HPGDALDH1A1GRIK1
SCHEMBL6710127 0.83 ROCK1 (0.47) NPC1RAB9AKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 NPC1 3891/4885RAB9A 3732/4885SMN1; SMN2 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.